Historical perspective
In the United States the literature contains only sporadic references to clinical disorders of Mg-deficiency, compared to more recent interest in the benefits of magnesium infusion in myocardial infarction and other acute clinical conditions [1, 2] . In Europe the clinical interest in Mg-deficiency was pioneered by Durlach in his book entitled Le Magnesium en Prutique Clinique; the English edition was entitled Magnesium in Clinical Practice [3] . In the conclusion of his book, Durlach stated: "This ion which is present in all the cells is involved in many different pathologies. Integrating a search for the disorders of magnesium metabolism in daily diagnostic processes allows determination of the indications and precise methods of magnesium therapy." In the United States, Seelig authored a text in 1980 entitled Magnesium Dejicicncy in the Parhogerzesis sf Disease [4] and reviewed the literature concerning magnesium requirements in human nutrition and the association of magnesium deficiency with cardiovascular disease [s] . That same year Wacker published an excellent book entitled Mugnesium und Mm in which he emphasized the clinical relevance of magnesium 161.
Six decades ago MacCollum [7l studied the effects of Mg-deficiency on development, reproduction, neuromuscular and humoral abnormalities in animals. In 1959 Bajusz and Selye published a paper describing the influence of electrolytes in the process of myocardial injury [8] . More recently, Lehr focused attention on magnesium and the process of cardiac necrosis [9] , or cardiomyopathic lesions which had been described earlier [lo] . B.T. Altura and B.M. Altura published a series of papers which postulated a working hypothesis for the detrimental effect of Mg-deficiency in cardiac pathology and heart failure [ 1 l-133 based upon the hypothesis that Mg-deficiency results in calcium overload, vasospasms, and increased vascular reactivity. Recent studies to elaborate on their model demonstrate that perfusion of isolated working rat hearts with low concentrations of extracellular Mg (0.3 mM) resulted in myocardial injury consistent with irreversible myocyte injury, which they conclude is probably a result of coronary vasoconstriction [l4]. Other investigators have contributed abundantly to the literature of the field for the past three decades [ 15-181. Thus, interest in the study of Mg-deficiency in animals began early in this century, but our understanding of the complex mechanisms leading to injury of the heart, and other organs remains incomplete.
Free radical mechanisms
When our research group entcrcd the field in the late 1980's, through collaboration with Dr. S. Bloom, we initially focused on whether the pathobiology of dietary Mg-deficiency might be related to free radical mechanisms. Using both the Mg-deficient hamster and rat, we embarked upon a series of antioxidant intervention studies. Animals were placed on Mg-deficient diets and concurrently treated with subcutaneously implanted pellets containing probucol [ 191 vitamin E [20] , and other antioxidants [21-231. This diet induced a severe deficiency in total serum Mg within a week of the animals being placed upon the diet, with serum levels below 0.3 mM after 1-2 weeks on the diet. However, total tissue Mg is relatively conserved during this time [24] . Using morphological end- points we observed that the myocardial lesions were diminished significantly by concurrent treatment with antioxidants. We postulated that this was evidence that free radicals contributed to the injury process. However, these radicals are known to be associated with many injury processes including inflammation and ischemia/reperfusion. Mammalian tissues contain numerous defenses against oxidative stress, some of which have been shown to be compromised during Mg-deficiency. Glutathione, a thiolcontaining tripeptide present in millimolar amounts in most mammalian cells, plays an important protective role against cellular oxidative injury by detoxifying free radicals and lipid peroxides. We demonstrated in rats that the level of glutathione in the red blood cells (RBCS) was significantly reduced after 2-3 weeks on a Mg-deficient diet; changes were observed in the Mg-deficient hamster [25] in which the level of RBC glutathione decreased 62% (from 1.22 to 0.36 pmol GSH/ml packed cells) within 2 weeks. In the swine, the GSH levels decreased w 45% after 7 weeks on the Mg-deficient diet [26] . Mg-deficiency also leads to a decrease in ascorbate in liver [27] brain [28] , and other tissues. Ascorbate is known to regenerate reduced vitamin E from oxidized vitamin E, and loss of ascorbate during Mg-deficiency suggests a possible subsequent loss of the reduced form of vitamin E [29] .
Other evidence that endogenous antioxidant defense is compromised during Mg-deficiency includes the accumuIation of oxidation products. Rats fed a Mg-deficient diet have a 40% increase in lipid peroxidation in the liver [30] . In our study with the rat, after 2 weeks on the deficient diet, the circulating plasma oxidized lipids, determined as thiobarbutaric-acid-reactive substances, increased from 0.82 f .20 to 1.92 + .25 nmol malondialdehyde/ml (P < 0.01) [31] . Concomitantly, significant (P < 0.05) accumulation of protein oxidation products, determined as protein-carbonyls, occurred in the kidney (increased from 2.7 to 5.2 nmol/mg protein) and in the brain (from 1.6 to 3.2 nmol/mg protein) [32] .
Plasma catecholamine levels also increase during Mgdeficiency, and auto-oxidation of catecholamines results in the generation of free radicals [33]+ Free radicals may play a major role in the development of cardiomyopathies in other experimental models: hyperoxia-induced toxicity, myocardial iron overload, and selenium-deficiency which causes inhibition of a key antioxidant enzyme.
Myocardial lesions due to Mg-deficiency in the hamster [20] and rat [21,34] models were blocked by long-term treatment with the lipid-soluble antioxidant, vitamin E. In a separate study, we showed that epi-captopril, an SH-containing agent, provided effective protection against the Mg-deficiency cardiomyopathic lesions [35] . In these antioxidant studies, the animals remained Mg-deficient even with antioxidant supplements, so the protection against lesion formation was not associated with correction of the hypomagnesemia. Epi-captopril is water-soluble and has no significant ACE-inhibitory activity. Since both captopril and epi-captopril (lo-50 PM) displayed 20-50% inhibition of OH radical level formation monitored by electron spin resonance (ESR) spin-trapping using 5,5-dimethyl-lpyrroline-N-oxide (DMPO) as the spin trap, we suggested that the protective effect was due to a free radical scavenging action of the SH-moiety [36], The inhibition of lesion formation by antioxidant therapy and the increase in oxidation products during Mg-deficiency provided indirect evidence that the endogenous antioxidant defenses may be compromised during Mg-deficiency. This finding may result from either oxidative loss of endogenous antioxidants during Mg-deficiency, or may indicate that antioxidants are insufficient to cope with increased levels of oxidative stress during Mg-deficiency. Mg-deficiency may predispose cells to oxidative injury. We showed that red blood cells (RBC) from Mg-deficient hamsters were more susceptible than those from Mg-sufficient hamsters to exogenous free radicals [25] . Moreover, we found that RBC's from Mg-deficient animals treated with vitamin E recovered their resistance to exogenouslygenerated free radicals. Further studies suggested that Mgdeficient tissues were less tolerant to oxidative stress (Table 1). Isolated working rat hearts from Mg-deficient rats were exposed to ischemia/reperfusion injury and they displayed a significant further impairment of functional recovery compared to Mg-sufficient animals following either 30 or 40 min of ischemia [37] . Mg-deficiency also caused significantly higher myocardial production of lipid peroxidation-derived free radicals following ischemia/reperfusion [37, 38] , as detected by electron spin resonance spin trapping using cu-phenyl-N-terr-butylnitrone (PBN) as the trapping agent. The elevated production of alkoxyl radicals (as PBN-RO . >, in Mg-deficient compared to Mg-sufficient hearts (Table 11 , suggested that lipid peroxidation above that usually expected was occurring during repet-fusion of previously ischemic Mg-deficient hearts. Again, vitamin E supplementation was found to attenuate free radical production in the ischemic/reperfused Mg-de-ficient rat heart and improve myocardial functional recovery [37] . As presented earlier, increased protein oxidation also occurred during Mg-deficiency. Therefore, it is reasonable to anticipate that, in addition to lipid peroxidation, protein sulphydryl oxidation might also occur and thus affect related protein function as well.
These results allowed us to conclude that free radicals mediated much of the tissue injury in Mg-deficiency since: oxidative products accumulate during Mg-deficiency [30,31]; Mg-deficiency reduces antioxidant status in tissues and cells so that they are more susceptible to ischemia/reperfusion [37, 38] 
provided evidence that Mg-deficiency induced ferrylmyoglobin formation and caused cardiac failure. The oxidation of myoglobin was inhibited by incubation with ascorbate, which improved cardiac function. Furthermore, this injury reported for cardiac exposure to modified Krebs-Henseleit bicarbonate buffer containing low Mg (0.3 mM) was not reversible by subsequent perfusing with the same buffer supplemented with normal (1.2 mM) Mg [14] . However, in our laboratory no difference could be observed in cardiac function from hearts isolated from rats on a Mg-deficient or Mg-sufficient diet for up to 4 weeks when isolated hearts from both were perfused with normal (1.2 mM) levels of Mg. These differences in response of acute versus chronic hypomagnesemic hearts indicate the importance of assessing pathobiological responses in both kinds of models.
Inflammation: cytokines and neuropeptides
In recent studies we have shown that Mg-deficiency has a profound effect on the process of inflammation, causing high circulating amounts of interleukins (IL-l, IL-61 and tumor necrosis factor-alpha (TNFcr ) [40] . These inflammatory modulators are elevated in rats, mice, and swine, and we have not found evidence of viral or bacterial infection in the animals. These findings suggest that dietary Mg-deficiency induces an unexpected rise in these mediators. These peptides are known to elicit free radical production in a variety of cell types, including endothelial cells and circulating white blood cells. Following activation of endothelial cells by these inflammatory cytokines, cytotoxic processes involving the production of oxygen free radicals can be ameliorated by antioxidant therapy both in vitro and in vivo [41, 42] .
We decided to study the temporal events of the Mg-deficiency-mediated inflammatory process, and found that specific cytokines, (ILl, IL6 and TNFo) were elevated only at the end of 2 weeks on the Mg-deficient diet [40, 43] . They were associated temporally with the increasing occurrence of cardiomyopathic lesions. We were puzzled by the fact that free-radical-related changes (increase in malonyldialdehyde and lipid hydroperoxide production) and decrease in RBC glutathione occurred only during the second week of Mg-deficiency [31,37], and that these changes preceded significant cardiac lesion production and significant elevations of inflammatory cytokines (Fig. 1) . We hypothesized that there should be an earlier "trigger" mechanism which induced the later changes in free radical stress, cytokine levels, and lesion formation.
In an effort to determine the mechanism responsible for this early trigger mechanism we considered the possibility that neuropeptides, and specifically substance P, could trigger this inflammation via various cell types of the immune system [44, 45] . Substance P was chosen based upon several known responses to Mg-deficiency. Mg-deficiency results in enhanced convulsive activity in response to auditory stimuli. We reasoned that there might be a relationship between the neuronal events in these animals and the observed cardiovascular pathology. Of the neuropeptides which could be possible involved, substance P was deemed a likely candidate because it is a known initiator of free radical production and neurogenic inflammation; it also causes histamine release, and proliferation of WBC's, both of which occur early during Mg-deficiency. To our satisfaction we found that both plasma substance P and calcitonin-gene-related peptide (CGRP) were elevated during the first week of Mg-deficiency in association with substantial hypomagnesemia (Fig. 2) . These elevations coincided with increases in PGE,, a prostaglandin involved in inflammation [43] , and preceded elevation of histamine and y-interferon.
Based on the fact that substance P (and CGRP) increased before other changes observed in our Mg-deficient model (Fig. 2) , we reasoned that it must be playing a role in the subsequent pathology. To test this hypothesis, we inhibited the action of substance P in the Mg-deficient animals by the use of a specific substance P receptor blocker [38, 46, 47] . Up until that time, other investigators reported depletion of substance of P using capsaicin as a strategy to study the role of this neuropeptide in pathology [48, 49] . Fortunately, a newly developed specific substance P NK-1 receptor blocker, CP-96,345 [50] , became available from work by investigators from the Pfizer laboratories. We were provided with this agent and proceeded to treat Mg-deficient and Mg-sufficient animals with sustained release pellets containing CP-96,345. In those Mgdeficient animals treated continuously with the substance P receptor blocker, we found significant reductions in cardiac lesion number and size (Table 21 , as well as significant decreases in plasma PGE, and histamine [46] . Additional data indicated that RBC glutathione, a good indicator of oxidative stress, was preserved in those animals pretreated with CP-96,345 (Table 2 ) [38] . From these observations we were able to postulate a neurogenic inflammation mechanism that resulted from early release of neuropeptides, which induced inflammatory responses in Mg-deficient animals, with subsequent free radical production and lesion formation. Since the circulating levels of substance P were not affected by substance P receptor blockade, we directly analyzed the cardiac lesions by a microdissection technique to ascertain whether there were any effects of the blocker on tissue concentrations of substance P. The methodology involved preparing frozen sections of cardiac tissue, identifying lesions, microdissecting them, solubilizing the samples, and injecting aliquots Mg-deficiency, -Substance P 0 into high-performance capillary electrophoresis columns for separation. We were able to show significant accumulation of neuropeptides in the microvascular lesions of Mgdeficient hearts (Table 3) ; however, in the normal-appearing cardiac tissue of deficient animals we saw only minimal neuropeptide elevations [47] . Thus, these studies localized neuropeptides within the cardiac lesions, and in those animals treated with the substance P receptor blocker we confirmed significant diminution of neuropeptides (Table  3) . We viewed this as strong evidence for the involvement of neuropeptides in myocardial lesion formation.
These experiments raised new questions and provided some answers to explain the mechanisms leading to the Mg-deficiency cardiomyopathy. Our ability to reverse the pathobiology with neuropeptide receptor blockade convinced us that neuropeptides were a significant initiator of the pathogenic cascade leading to cardiac lesion formation, and that they probably involved other tissues such as the lungs, brain and kidneys. Fig. 3 depicts our expanded concept of the role of neuropeptides in the cascade of systemic cellular injury leading to enhanced free radical production, oxidation of proteins and lipids, and ultimately, cardiovascular injury.
Clinical relevance
The case of a patient presenting with profound Mg-deficiency due to alcoholism points to some causal role for magnesium in the observed multifaceted clinical pathology. The fact that the patient endured cardiovascular injury, pancreatic injury, and hepatic injury suggests a systemic process. Does the mechanism of injury include neurogenic peptide-triggered free radical production that results in multiorgan injury? We do not know at this time, but as our clinical diagnostic tools improve in the future we may be able to characterize the pathobiology of Mg-deficiency in man more accurately than we are able to do so today with atomic absorption analysis of plasma samples, which, while it measures total magnesium, does not provide information about ionized magnesium. New studies report the ability to detect levels of free magnesium rather than measuring total (bound plus free) magnesium in the plasma, using electrodes that are more specific for ionized magnesium in plasma. These techniques may help to enhance the diagnostic ability of clinicians who suspect Mg-deficiency as they become more widely utilized. Atother interesting diagnostic modality is the use of a photofluorescent indicator of various ions within cells. The intravenous administration of magnesium and the subsequent quantification of the excreted portion of the magnesium is another test that identifies patients with a chronic deficit of magnesium, since they retain a much higher percentage of the intravenous magnesium [511. The present difficulty in diagnosing Mg-deficiency is not unlike that of the problems detecting cholesterol disorders prior to the 1960's when more sophisticated electrophoretic techniques were established. With increasing fractionation of lipoproteins, a whole new therapeutic approach to patients with hypercholesterolemia was adopted by clinicians over the ensuing decades. Perhaps the field of Mg-deficiency-associated pathobiology will be advanced more rapidly when newer, more sophisticated diagnostic methodologies are applied routinely in the clinic and hospital. Only then will we be able to establish more firmly the multiple role of deficiency of this mineral in the etiology of disease in man. 
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